Wen-Ming Cao (Wenming Cao)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Clostridium Difficile

Circulating Tumor

Top Venues

Nature communications

Therapeutic advances in medical oncology

NPJ breast cancer

Molecular genetics & genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Qiao-Yan Zhu, Yu-Yang Liao, Xiao-Wen Ding, Lin-Feng Zheng, Wen-Ming Cao
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis. Therapeutic advances in medical oncology 16 (2024)
Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Qiao-Yan Zhu, Yu-Yang Liao, Xiao-Wen Ding, Lin-Feng Zheng, Wen-Ming Cao
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis. Therapeutic advances in medical oncology 16 (2024)
Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Qiao-Yan Zhu, Yu-Yang Liao, Xiao-Wen Ding, Lin-Feng Zheng, Wen-Ming Cao
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis. Therapeutic advances in medical oncology 16 (2024)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Zi-Yan Yang, Jianguo Feng, Ji Jing, Yuan Huang, Wei-Wu Ye, Lei Lei, Xiao-Jia Wang, Wen-Ming Cao
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer. NPJ breast cancer 9 (1) (2023)
Zi-Yan Yang, Jianguo Feng, Ji Jing, Yuan Huang, Wei-Wu Ye, Lei Lei, Xiao-Jia Wang, Wen-Ming Cao
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer. NPJ breast cancer 9 (1) (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Jie Sun, Futao Chu, Jia-Ni Pan, Yaxin Zhang, Lu Yao, Jiuan Chen, Li Hu, Juan Zhang, Ye Xu, Xiao-Jia Wang, Wen-Ming Cao, Yuntao Xie
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Liang Zhu, Jia-Ni Pan, Ziliang Qian, Wei-Wu Ye, Xiao-Jia Wang, Wen-Ming Cao
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer. Breast cancer (Tokyo, Japan) (2021)
Jia-Ni Pan, Lei Lei, Wei-Wu Ye, Xiao-Jia Wang, Wen-Ming Cao
BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis. Journal of breast cancer 24 (5) (2021)
Jiawei Li, Xin Guan, Zhimin Fan, Lai-Ming Ching, Yan Li, Xiaojia Wang, Wen-Ming Cao, Dong-Xu Liu
Non-Invasive Biomarkers for Early Detection of Breast Cancer. Cancers 12 (10) (2020)
Huanhuan Zhou, Xiao-Jia Wang, Xiyi Jiang, Ziliang Qian, Tianhui Chen, Yue Hu, Zhan-Hong Chen, Yun Gao, Rong Wang, Wei-Wu Ye, Wen-Ming Cao
Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse. Breast cancer research and treatment 178 (1) (2019)
Zhanhong Chen, Tian Sun, Zi-Yan Yang, Yabing Zheng, Ruoying Yu, Xue Wu, Junrong Yan, Yang W Shao, Xiying Shao, Wen-Ming Cao, Xiao-Jia Wang
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling. Molecular genetics & genomic medicine 8 (2) (2019)